44 related articles for article (PubMed ID: 4538330)
1. A new sustained-release tablet formulation of procainamide.
Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
[No Abstract] [Full Text] [Related]
2. Myotonic dystrophy and multiple sclerosis.
Terrence CF
J Neurol; 1976 Oct; 213(4):305-8. PubMed ID: 62029
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus: clinical and serological studies.
Harmon CE; Portanova JP
Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
[No Abstract] [Full Text] [Related]
4. Lupus-like syndromes induced by drugs.
Harpey JP
Ann Allergy; 1974 Nov; 33(5):256-61. PubMed ID: 4138815
[No Abstract] [Full Text] [Related]
5. Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.
Anastassiades TP; Miliiken JA
Can Med Assoc J; 1972 Aug; 107(4):312-5. PubMed ID: 4538330
[No Abstract] [Full Text] [Related]
6. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
Ullman S; Wiik A; Kobayasi T; Halberg P
Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
[No Abstract] [Full Text] [Related]
7. [The reversible procaine amide-induced lupus-erythromatosus syndrome].
Günther R; Asamer H; Dittrich P
Dtsch Med Wochenschr; 1969 Nov; 94(45):2338-42. PubMed ID: 4186711
[No Abstract] [Full Text] [Related]
8. Antinuclear antibody induced by procainamide. A prospective study.
Blomgren SE; Condemi JJ; Bignall MC; Vaughan JH
N Engl J Med; 1969 Jul; 281(2):64-6. PubMed ID: 4182059
[No Abstract] [Full Text] [Related]
9. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
[TBL] [Abstract][Full Text] [Related]
10. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
Dixon JA; Mulhern LM; Whiteside TL; Luksick J
J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
[TBL] [Abstract][Full Text] [Related]
11. The use of procaine amide in cardiac arrhythmias.
KAYDEN HJ; STEELE JM; MARK LC; BRODIE BB
Circulation; 1951 Jul; 4(1):13-22. PubMed ID: 14848947
[No Abstract] [Full Text] [Related]
12. PULMONARY DISEASE IN MYOTONIC DYSTROPHY.
PRUZANSKI W; PROFIS A
Am Rev Respir Dis; 1965 Jun; 91():874-9. PubMed ID: 14294710
[No Abstract] [Full Text] [Related]
13. Procainamide-induced lupus erythematosus.
LADD AT
N Engl J Med; 1962 Dec; 267():1357-8. PubMed ID: 13927984
[No Abstract] [Full Text] [Related]
14. The treatment of myotonia: a controlled clinical trial.
LEYBURN P; WALTON JN
Brain; 1959 Mar; 82(1):81-91. PubMed ID: 13651495
[No Abstract] [Full Text] [Related]
15. Treatment of myotonia with procainamide.
MACROBBIE DS; FRIEDLANDER WJ
AMA Arch Neurol Psychiatry; 1957 Nov; 78(5):473-5. PubMed ID: 13468838
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
